MetLife, Inc. (MET) Cash Flow Statement

The consistent ability to generate operating cash flow in excess of net income suggests that the core underwriting engine remains a reliable source of liquidity. Investors should monitor whether the periodic spikes in claims payments, such as the $16.5 billion observed in 2025Q4, represent temporary seasonal fluctuations or a more permanent shift in the underlying risk profile of the group benefits portfolio.

The high turnover in the investment portfolio appears to be a strategic response to the current interest rate environment, aiming to capture yield improvements while managing duration risk. This level of activity warrants further investigation into the potential for realized gains or losses to create noise in the cash flow statement, potentially obscuring the underlying cash yield of the portfolio.

This divergence suggests that traditional earnings metrics may be insufficient for assessing the company's true financial health, as they are heavily influenced by accounting conventions rather than cash-based performance. Analysts should focus on the cash flow conversion metrics to better understand the sustainability of capital returns in the face of potential reserve adjustments.

The reliance on share repurchases as a primary capital allocation tool appears to be a strategy to manage the equity base, though it may limit flexibility if cash generation were to face unexpected pressure from the legacy portfolio. Investors should monitor whether the current pace of buybacks remains sustainable if the company chooses to prioritize organic growth or further expansion of its fee-based asset management business.